Another stock that insiders are loading up in here is medical equipment and supplies player Nanosphere (NSPH), which develops, manufactures, and markets molecular diagnostics platform, the Verigene System that enables genomic and protein testing on a single platform. Insiders are jumping into this stock into strength since shares are up 36% so far in 2012.
Nanosphere has a market cap of $87 million and an enterprise value of $52 million. This stock trades at a fair valuation, with a price-to-sales of 26.43 and a price-to-book of 2.21. Its estimated growth rate for this year is 18.1%, and for next year it's pegged at 24.7%. This is a cash-rich company, since the total cash position on its balance sheet is $31.76 million and its total debt is zero.A director and beneficial owner just bought 342,500 shares, or around $598,000 worth of stock, at $1.75 per share. >>5 Stocks Setting Up to Break Out From a technical perspective, NSPH is currently trading above both its 50-day and 200-day moving averages, which is bullish. This stock has been trading range bound for the past two months, with shares bouncing around $1.51 to $2 a share. Just recently, shares of NSPH have started to break out above some near-term overheads resistance $1.92 a share. That move is quickly pushing the stock within range of triggering an even bigger breakout trade. If you're in the bull camp on NSPH, I would look for long-biased trades if this stock can manage to trigger a break out above some near-term overhead resistance at $2.17 to $2.21 a share with high-volume. Look for volume on that move that hits near or above its three-month average action of 222,412 shares. If we get that action soon, then NSPH could easily tag its next significant overhead resistance levels at $2.41 to $3 a share or possibly even higher. One could also look to buy this stock off any weakness as long as some near-term support at $1.80 holds up. I would avoid this name if it takes out its 50-day at $1.76 and its 200-day at $1.61 with heavy volume.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV